A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Geron

Geron is focused on developing and commercializing therapeutic and diagnostic products for cancer based on their telomerase technology, and cell-based therapeutics using their human embryonic stem cell technology.

--Telomerase is an enzyme (see: telomere) that is expressed in nearly all cancer cells, but not in most normal cells. Geron hopes to kill cancer cells in which telomerase is abnormally expressed by inhibiting or targeting telomerase, and to diagnose cancer by measuring telomerase activity.

--Human embryonic stem cells can develop and differentiate into all cells and tissues in the body. As such, they are a potential source for the manufacture of replacement cells and tissues for organ repair applications in chronic diseases.


Product Pipeline for Geron-- Patient Information


Cancer Programs : Telomerase Cancer Vaccine (TVAX)

Telomerase Cancer Vaccine --Telomerase Inhibitor --Human Embryonic Stem Cell Programs


Stem Cell Programs


More on Geron

Home Page

Key Statistics for Geron

Basic Chart for Geron

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.